Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 weight-loss treatments grows.

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Weight loss medication Wegovy is now available in pill form, offering the same active ingredient as weekly injections.

Avenacy, a specialty pharmaceutical company that supplies injectable medications, launched Eptifibatide for Injection, a generic for Merck’s Integrilin. Eptifibatide for Injection is indicated for use ...

In the first human trial of a new therapeutic, a single injection of lepodisiran reduced levels of lipoprotein(a), or Lp(a), to undetectable levels for nearly one year, according to late-breaking ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...